Table 2

Characteristics Associated with Decreased Survival among VA Patients with Diabetes, Schizophrenia, or Both Diabetes and Schizophrenia (N = 241,466)

Parameter

Hazard Ratio

Pr > ChiSq


Age in Decades (range 5–10)

1.72

<.0001


Female

0.69

<.0001


Married

0.74

<.0001


Black

0.99

0.5030


Hispanic

1.00

0.9348


Missing Data on Race

0.73

<.0001


Vietnam Era

1.05

0.0023


Priority Status – Referent: Priority 1


Priority Status 2

0.93

0.0046


Priority Status 3

0.96

0.0496


Priority Status 4

1.36

<.0001


Priority Status 5

1.01

0.5910


Priority Status 6

0.95

0.6357


Priority Status 7

0.79

<.0001


Priority Status 8

0.74

0.0582


Selim Physical Comorbidity Score (range 0–15)

1.10

<.0001


Number of Medication Classes at Baseline (range 0–42)

1.07

<.0001


Loss of System Contact During Study Period

1.17

<.0001


Primary Care Trajectory by Diagnosis Subgroups – Referent: Consistent Care – Diabetes Only


Increasing Primary Care – Schizophrenia

0.26

<.0001


Consistent Primary Care – Schizophrenia

0.95

0.2781


Low-Decreasing Primary Care – Schizophrenia

4.20

<.0001


High-Decreasing Primary Care – Schizophrenia

1.31

0.0002


Increasing Primary Care – Schizophrenia with Diabetes

0.48

<.0001


Consistent Primary Care – Schizophrenia with Diabetes

1.01

0.8176


Low-Decreasing Primary Care – Schizophrenia with Diabetes

5.01

<.0001


High-Decreasing Primary Care – Schizophrenia with Diabetes

1.44

<.0001


Increasing Primary Care – Diabetes Only

0.38

<.0001


Low-Decreasing Primary Care – Diabetes Only

3.85

<.0001


High-Decreasing Primary Care – Diabetes Only

1.59

<.0001


Copeland et al. BMC Health Services Research 2009 9:127   doi:10.1186/1472-6963-9-127

Open Data